4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-000177
President & CEO gave up 48,211 shares (to pay taxes)
- President & CEO acquired 700,000 shares (grant or award)
- President & CEO acquired 102,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew President & CEO | 2026-02-13 | Grant or award | +700,000 | 1,123,145 | D: show line 1 in the form | ||
| Hirsch Andrew President & CEO | 2026-02-14 | Option exercise | +81,725 | 1,123,145 | D: show line 2 in the form | ||
| Hirsch Andrew President & CEO | 2026-02-14 | Shares withheld for taxes | −39,154 | $1.89 | $74,001 | 1,083,991 | D: show line 3 in the form |
| Hirsch Andrew President & CEO | 2026-02-15 | Option exercise | +20,400 | 1,083,991 | D: show line 4 in the form | ||
| Hirsch Andrew President & CEO | 2026-02-15 | Shares withheld for taxes | −9,057 | $1.89 | $17,118 | 1,074,934 | D: show line 5 in the form |
Loading xslF345X05/wk-form4_1771452294.xml…